10 Feb 2022 , 08:13 AM
Net profit of Aurobindo Pharma declined 79.49% to Rs 604.73 crore in the quarter ended December 2021 as against Rs 2948.06 crore during the previous quarter ended December 2020. Sales declined 5.72% to Rs 5989.43 crore in the quarter ended December 2021 as against Rs 6353.13 crore during the previous quarter ended December 2020.
| Particulars | Quarter Ended | ||
| ? | Dec. 2021 | Dec. 2020 | % Var. |
| Sales | 5989.43 | 6353.13 | -6 |
| OPM % | 16.85 | 21.31 | – |
| PBDT | 1058.04 | 1468.03 | -28 |
| PBT | 758.99 | 1191.51 | -36 |
| NP | 604.73 | 2948.06 | -79 |
Powered by Capital Market – Live News
Related Tags

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.